Kendall Capital Management’s GSK GSK Stock Holding History

Kendall Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.67M	Buy	50,941 +7,175	+16%	+$379K	0.44%	53
2026 Q1	$2.42M	Buy	43,766 +1,810	+4%	+$98.1K	0.5%	54
2025 Q4	$2.06M	Buy	41,956 +9,015	+27%	+$420K	0.43%	58
2025 Q3	$1.42M	Buy	32,941 +7,495	+29%	+$293K	0.32%	72
2025 Q2	$977K	Buy	25,446 +11,050	+77%	+$422K	0.26%	100
2025 Q1	$558K	Buy	+14,396	New	+$527K	0.16%	140

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Kendall Capital Management's GSK Position: Q2 2026 in Review

Kendall Capital Management increased its GSK (GSK) stake by 16% in Q2 2026, buying an estimated $379K and bringing the position to 50,941 shares worth $2.67M. The position accounts for 0.44% of the portfolio, ranked #53.

Kendall Capital Management first reported a position in GSK in Q1 2025 and has held it in 6 quarters since. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Kendall Capital Management held 50,941 shares of GSK worth $2.67M as of Q2 2026.
Kendall Capital Management bought 7,175 GSK shares in Q2 2026, an estimated $379K.
GSK made up 0.44% of Kendall Capital Management's portfolio in Q2 2026, its #53 holding.
Kendall Capital Management first reported a position in GSK in Q1 2025 and has held it in 6 quarters since.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Kendall Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.